CCCCCCNC(=O)O[C@H]1C[C@H](C(=O)OC)[C@H](C(=O)OC)C2CN(S(=O)(=O)c3ccc(C)cc3)C[C@@]21O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?